SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079974-18-000674
Filing Date
2018-12-19
Accepted
2018-12-19 11:22:42
Documents
59
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 apotheca10q_10312018.htm 10-Q 228207
8 CERTIFICATION PURSUANT TO SECTION 302 ex311.htm EX-31 13484
9 SECTION 1350 CERTIFICATION ex321.htm EX-32 9537
  Complete submission text file 0001079974-18-000674.txt   1745386

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE FILE pcfp-20181031.xml EX-101.INS 224378
3 XBRL SCHEMA FILE pcfp-20181031.xsd EX-101.SCH 34074
4 XBRL CALCULATION FILE pcfp-20181031_cal.xml EX-101.CAL 36852
5 XBRL DEFINITION FILE pcfp-20181031_def.xml EX-101.DEF 65449
6 XBRL LABEL FILE pcfp-20181031_lab.xml EX-101.LAB 163684
7 XBRL PRESENTATION FILE pcfp-20181031_pre.xml EX-101.PRE 140716
Mailing Address 10901 ROOSEVELT BLVD., SUITE 1000C SAINT PETERSBURG FL 33716
Business Address 10901 ROOSEVELT BLVD., SUITE 1000C SAINT PETERSBURG FL 33716 727-228-3994
Apotheca Biosciences, Inc. (Filer) CIK: 0001632053 (see all company filings)

IRS No.: 472055848 | State of Incorp.: NV | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 000-55467 | Film No.: 181242698
SIC: 1000 Metal Mining
Office of Energy & Transportation